Tasimelteon ( DrugBank: Tasimelteon )

1 disease

ID	Disease name (Link within this page)	Number of trials
202	Smith-Magenis syndrome	2

202. Smith-Magenis syndrome

Clinical trials : 10 / Drugs : 12 - (DrugBank : 5) / Drug target genes : 4 - Drug target pathways : 7

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02776215 (ClinicalTrials.gov)	September 2016	16/5/2016	Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents	Open-label Study to Investigate the Pharmacokinetics and Safety of Tasimelteonin Children and Adoles ...	Circadian Rhythm Sleep Disorders;Non-24 Hour Sleep-Wake Disorder;Autism Spectrum Disorder;Smith-Mage ...	Drug: tasimelteon	Vanda Pharmaceuticals	NULL	Recruiting	3 Years	17 Years	All	24	Phase 1	United States
2	NCT02231008 (ClinicalTrials.gov)	September 2015	29/8/2014	Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS		Smith-Magenis Syndrome;Circadian	Drug: tasimelteon	Vanda Pharmaceuticals	NULL	Recruiting	16 Years	65 Years	Both	48	Phase 2/Phase 3	United States

First Previous1Next Last